genOway S.A.
ALGEN.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €9,603 | €11,349 | €10,710 | €10,714 |
| % Growth | -15.4% | 6% | -0% | – |
| Cost of Goods Sold | €0 | €6,481 | €6,324 | -€8,486 |
| Gross Profit | €0 | €7,814 | €6,912 | €19,201 |
| % Margin | 0% | 68.9% | 64.5% | 179.2% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €40,294 | €337 | €4,501 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €9,468 | -€33,594 | €5,878 | €3,274 |
| Operating Expenses | €9,468 | €6,700 | €6,215 | €7,775 |
| Operating Income | €135 | -€1,214 | -€1,265 | -€2,509 |
| % Margin | 1.4% | -10.7% | -11.8% | -23.4% |
| Other Income/Exp. Net | -€135 | €309 | €208 | €1,216 |
| Pre-Tax Income | €0 | -€905 | -€1,057 | -€1,293 |
| Tax Expense | €143 | €2,198 | -€1,764 | -€1,842 |
| Net Income | €143 | €1,125 | €706 | €550 |
| % Margin | 1.5% | 9.9% | 6.6% | 5.1% |
| EPS | 0.015 | 0.11 | 0.076 | 0.062 |
| % Growth | -86.8% | 44.5% | 22.3% | – |
| EPS Diluted | 0.015 | 0.11 | 0.076 | 0.062 |
| Weighted Avg Shares Out | 9,848 | 9,848 | 9,277 | 8,840 |
| Weighted Avg Shares Out Dil | 9,848 | 9,848 | 9,277 | 8,840 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €118 | €140 | €26 |
| Interest Expense | €77 | €44 | €102 | €65 |
| Depreciation & Amortization | €0 | €1,304 | €1,282 | €3,050 |
| EBITDA | €382 | €443 | €327 | €5,712 |
| % Margin | 4% | 3.9% | 3.1% | 53.3% |